Prostate cancer navigation: initial experience and association with time to care.

World Journal of Urology
Emily C SerrellJesse D Sammon

Abstract

To evaluate factors associated with use of patient navigation in a prostate cancer population and identify whether navigation is associated with prolonged time to care. Cancer patient navigation has been shown to improve access to cancer screening, diagnosis, and treatment, but little is known about patient navigation in prostate cancer care. All men diagnosed with localized prostate cancer between 2009 and 2015 were abstracted from the MaineHealth multi-specialty tumor registry. Regression analyses controlling for patient-, disease-, and system-level factors evaluated characteristics associated with navigation utilization. The association between navigation utilization, barriers to care, and longer time to treatment was assessed with Cox proportional hazards regression. Of the patient population (n = 1587), 85% of men were navigated. Navigation use was associated with earlier year of diagnosis, treatment by a high-volume urologist, and lower risk disease (p < 0.05). Treatment delay was associated with low-risk disease (vs: intermediate OR 0.62, 95% CI 0.46-0.85 and high OR 0.16, 95% CI 0.1-0.25) and receipt of navigation services (OR 1.65, 95% CI 1.12-2.45) but not distance to care, insurance, or treatment choice. We observed ...Continue Reading

References

Apr 1, 1996·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·G Borghede, M Sullivan
Oct 17, 1998·Cancer Nursing·M S TingenM C Weinrich
Sep 10, 2008·Cancer·Kristen J WellsUNKNOWN Patient Navigation Research Program
Oct 28, 2008·Cancer·Karen M FreundUNKNOWN Patient Navigation Research Program Group
Jun 11, 2011·CA: a Cancer Journal for Clinicians·Electra D PaskettKristen J Wells
Oct 10, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Peter C RaichUNKNOWN Denver Patient Navigation Research Program
Jan 19, 2013·Der Urologe. Ausg. A·N ErnstmannL Weißbach
Mar 5, 2013·European Urology·Roderick C N van den BerghHenk G van der Poel
Aug 21, 2013·BMC Health Services Research·Melissa A SimonAlfred W Rademaker
Jun 19, 2014·Journal of the National Cancer Institute·Karen M FreundUNKNOWN Writing Group of the Patient Navigation Research Program
Sep 16, 2014·The Cochrane Database of Systematic Reviews·France LégaréNorbert Donner-Banzhoff
Jan 15, 2015·Cancer·Sanja Percac-LimaAlexandra B Kimball
Mar 17, 2015·CA: a Cancer Journal for Clinicians·Philippe D VioletteKari A O Tikkinen
Aug 26, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chun Chieh LinDawn L Hershman
Feb 11, 2016·Education for Primary Care : an Official Publication of the Association of Course Organisers, National Association of GP Tutors, World Organisation of Family Doctors·George K Freeman
Oct 25, 2016·The Journal of Urology·David C JohnsonMatthew E Nielsen
Sep 15, 2016·The New England Journal of Medicine·Freddie C HamdyUNKNOWN ProtecT Study Group
Sep 21, 2016·Cancer·Elizabeth M WhitleyUNKNOWN Patient Navigation Research Program Investigators
Dec 21, 2016·Nature Reviews. Urology·Katherine FleshnerMonique J Roobol

❮ Previous
Next ❯

Citations

Nov 13, 2019·Journal of Community Health·Ryan W DobbsMichael R Abern
Aug 30, 2019·International Urogynecology Journal·Matthew RohloffJannah H Thompson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.